Global Remote Patient Monitoring And Care Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2024 –2030 |
 Taille du marché (année de référence) |
USD 25,769.22 million |
 Taille du marché (année de prévision) |
|
 TCAC |
% |
| Principaux acteurs du marché |
>Marché mondial de la surveillance et des soins à distance des patients, par type d'appareil (appareils de surveillance cardiaque, appareils de surveillance de la pression artérielle, appareils de surveillance de la glycémie, appareils de surveillance respiratoire, appareils de surveillance neurologique, appareils de surveillance multiparamétrique et autres), application (oncologie, diabète, maladies cardiovasculaires et autres), utilisateur final (patients hospitalisés, patients ambulatoires et patients recevant des soins à domicile) - Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse et perspectives du marché de la surveillance et des soins à distance des patients
L'approche RPM et soins en matière de prestation de soins de santé est devenue de plus en plus populaire ces dernières années, notamment en raison de la pandémie de COVID-19, qui a entraîné une demande accrue d'options de soins à distance. La sensibilisation croissante à la RPM et aux soins à l'échelle mondiale a renforcé la demande pour le marché. L'augmentation des dépenses de santé pour de meilleurs services de santé contribue également à la croissance du marché. Les principaux acteurs du marché se concentrent sur divers lancements et approbations de services pendant cette période cruciale. En outre, l'augmentation des progrès technologiques améliorés des appareils contribue également à la demande croissante de RPM et de soins.
Le marché mondial de la surveillance et des soins à distance des patients devrait croître au cours de l'année de prévision en raison de l'augmentation du nombre d'acteurs sur le marché et de la disponibilité d'appareils de surveillance à distance avancés. Parallèlement à cela, les fabricants sont engagés dans l'activité de développement pour lancer de nouveaux appareils et des produits RPM efficaces et précis sur le marché. Le développement croissant dans le domaine des techniques de soins de santé avancées stimule encore la croissance du marché. Cependant, des difficultés telles que les réglementations strictes pour la production et la commercialisation de RPM et de produits de soins devraient freiner la croissance du marché au cours de la période de prévision.
L'augmentation des dépenses consacrées au développement et à l'avancement des soins de santé devrait offrir des opportunités de croissance du marché. Cependant, le coût élevé des dispositifs de surveillance et de soins à distance devrait constituer un défi à la croissance du marché.
Diverses entreprises prennent des initiatives qui conduisent progressivement à une croissance du marché.
Par exemple,
- En janvier 2023, CoachCare a annoncé l'acquisition de la société RPM NVOLVE, basée à Winston-Salem, afin d'étendre son expertise RPM dans le domaine de la douleur, de la colonne vertébrale et de l'orthopédie. Cette acquisition aiderait l'entreprise dans son portefeuille de produits et son expansion commerciale.
Data Bridge Market Research analyse que le marché mondial de la surveillance et des soins à distance des patients devrait atteindre une valeur de 25 769,22 millions USD d'ici 2030, à un TCAC de 12,5 % au cours de la période de prévision 2023-2030.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Année historique |
2021 (personnalisable de 2015 à 2020) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD |
|
Segments couverts |
Type d'appareil (appareils de surveillance cardiaque, appareils de surveillance de la pression artérielle, appareils de surveillance de la glycémie, appareils de surveillance respiratoire, appareils de surveillance neurologique, appareils de surveillance multiparamétrique et autres), application (oncologie, diabète, maladies cardiovasculaires et autres), utilisateur final (patients hospitalisés, patients ambulatoires et patients recevant des soins à domicile) |
|
Pays couverts |
États-Unis, Canada, Mexique, Allemagne, France, Royaume-Uni, Italie, Espagne, Belgique, Turquie, Pays-Bas, Russie, Suisse, Reste de l'Europe, Chine, Japon, Inde, Corée du Sud, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines, Reste de l'Asie-Pacifique, Brésil, Argentine, Reste de l'Amérique du Sud, Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Israël et Reste du Moyen-Orient et de l'Afrique |
|
Acteurs du marché couverts |
Medtronic, Boston Scientific Corporation, VitalConnect, Biobeat, General Electric, Koninklijke Philips NV, OMRON Corporation, Abbott, Nihon Kohden Corporation, Vivify Health, Inc., Aerotel Medical Systems, BIOTRONIK SE & Co. KG, A&D Company, Limited, AliveCor, Inc., Masimo, Dexcom, Inc., Senseonics, Inc., ResMed, 100Plus., ChroniSense Medical, Ltd., Vitls, cardiomo, CoachCare, neteera et Withings, entre autres |
Définition du marché
La surveillance et les soins à distance des patients (RPM) constituent un modèle de prestation de soins de santé qui permet aux prestataires de soins de surveiller les patients à distance, à l'aide de divers appareils technologiques et outils de communication, sans avoir besoin de visites en face à face. Cette approche permet aux prestataires de soins de santé de prodiguer des soins et de suivre les données de santé des patients à distance, souvent en temps réel.
Le RPM implique généralement l'utilisation d'appareils portables dotés de capteurs et d'autres dispositifs technologiques qui peuvent suivre les signes vitaux d'un patient, l'observance du traitement, l'activité physique et d'autres informations liées à la santé. Les données collectées sont ensuite transmises aux prestataires de soins de santé qui peuvent analyser les informations et prendre les mesures appropriées, telles que l'ajustement des dosages des médicaments, la fourniture de conseils sur les changements de mode de vie ou la planification de rendez-vous de suivi.
Dynamique du marché mondial de la surveillance et des soins à distance des patients
Cette section traite de la compréhension des moteurs, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :
Conducteur
- Prévalence croissante des maladies chroniques
Le marché est en pleine expansion pour diverses raisons, notamment la prévalence croissante des maladies chroniques. Les maladies chroniques sont des maladies non transmissibles qui durent longtemps et nécessitent des soins médicaux et une gestion continus.
Selon l’Organisation mondiale de la santé, les maladies chroniques sont responsables de près de 70 % des décès dans le monde, les maladies cardiovasculaires étant la principale cause. La prévalence croissante des maladies chroniques est due à de nombreuses variables, notamment le vieillissement de la population, la sédentarité, la mauvaise alimentation et les facteurs environnementaux. La gestion des maladies chroniques et les soins peuvent aider les prestataires de soins de santé à gérer les maladies chroniques de manière plus efficace et efficiente.
As a result of the sedentary lifestyle of people, the prevalence of lifestyle-associated disorders such as hypertension and diabetes witnessed a rise. Thus, the rising prevalence of chronic diseases with the growing integration of healthcare data with portable devices is expected to demand proper health management, leading to the anticipated increasing demand for RPM and care in the market in the forecast period.
Restraint
- Strict Regulatory Framework
Regulatory bodies play a critical role in ensuring that remote patient monitoring technologies meet safety and quality standards and protect patient privacy. However, regulatory compliance can be a significant barrier to entry for many companies and may slow down the adoption of remote patient monitoring technologies.
The medical device regulations hold significant responsibility for safeguarding the health of the people in the medical device industry itself. The regulations require manufacturers to inculcate quality systems (based on internationally accepted standards for quality systems) into the design process for class III and IV devices. They also require manufacturers to incorporate them into the manufacturing process for class II, III, and IV devices.
Along with such strict regulations of medical devices, it has also been reported that Health Canada’s decision related to medical device applications is not timely. It involves reviewing the submission of scientific evidence by manufacturers to ensure the efficacy of various devices.
This suggests that such a tedious procedure led to the development of other technologically advanced devices and hence, poses a big challenge in front of device manufacturers in submitting the approval documentation.
The regulations imposed would delay the supply of the instrumentation and long-time approval for the devices. This factor is expected to act as a restraint for market growth.
Opportunity
-
Strategic Initiatives by Market Players
The strategic initiatives taken by the key market players have helped in the rise in technologies and advancements in remote patient monitoring products and devices. They are taking initiatives such as product launches, collaborations, mergers, and acquisitions among others, which is expected to create more opportunities for market growth.
Healthcare product suppliers have a huge opportunity to work with new technology firms to ensure the industry's continued growth, creativity, and viability.
To discover and develop advanced remote monitoring facilities, companies are launching new initiatives and collaborating with other key players to deliver more reliable results and services.
These strategic initiatives such as product launches, approvals, acquisitions, and mergers done by major companies in the market have opened up an opportunity for companies in various regions. This strategy is allowing the companies to strengthen their footprints in the market. Therefore, it is predicted that strategic initiative is expected to provide an opportunity for market growth.
Challenge
- Lack of Skilled Professionals
Remote patient monitoring requires a range of professionals with specialized knowledge and expertise, including clinicians, technicians, and data analysts.
Clinicians are responsible for monitoring patient's health remotely and interpreting the data collected by remote patient monitoring devices.
Moreover, technicians are responsible for installing, maintaining, and troubleshooting remote patient monitoring devices. Data analysts are responsible for analyzing the data collected by remote patient monitoring devices and providing insights to healthcare providers. However, there is currently a shortage of data analysts, clinicians, and technicians with the necessary skills and experience to provide meaningful insights from remote patient monitoring data.
The lack of skilled professionals can also limit the adoption of RPM technologies and limit their potential to improve healthcare outcomes. Without skilled professionals, healthcare providers may struggle to interpret patient data and provide appropriate interventions, limiting the effectiveness of RPM in improving patient outcomes. Thus, the lack of skilled professionals is a significant factor expected to pose a challenge to market growth.
Recent Developments
- In January 2023, Masimo and Philips announced an expansion of their partnership to augment patient monitoring capabilities in home telehealth applications with the Masimo W1 advanced health tracking watch. This collaboration extension would help the company in remote patient monitoring product portfolio expansion.
- In December 2022, Masimo announced the full market release of the Hydration Index (Hi) for the Masimo W1 watch. The Masimo W1, an advanced health-tracking wearable, is the first watch to offer accurate, continuous pulse oximetry measurements and insightful health data, from the leader in hospital pulse oximetry. This product upgradation would help the company in product business expansion.
Global Remote Patient Monitoring and Care Market Scope
The global remote patient monitoring and care market is segmented into three notable segments such as device type, application, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Device Type
- Cardiac Monitoring Devices
- Blood Pressure Monitoring Devices
- Blood Glucose Monitoring Devices
- Respiratory Monitoring Devices
- Neurologiocal Monitoring Devices
- Multi-Parameter Monitoring Devices
- Others
On the basis of device type, the market is segmented into cardiac monitoring devices, blood pressure monitoring devices, blood glucose monitoring devices, respiratory monitoring devices, neurological monitoring devices, multi-parameter monitoring devices, and others.
Application
- Oncology
- Diabetes
- Cardiovascular Diseases
- Others
On the basis of application, the market is segmented into oncology, diabetes, cardiovascular diseases, and others.
End User
- Hospital-Based Patients
- Ambulatory Patients
- Home Healthcare Patients
On the basis of end user, the market is segmented into hospital-based patients, ambulatory patients, and home healthcare patients.
Global Remote Patient Monitoring and Care Market Regional Analysis/Insights
The global remote patient monitoring and care market is segmented into three notable segments such as device type, application, and end user.
The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Belgium, Turkey, Netherlands, Russia, Switzerland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.
North America is expected to dominate the global remote patient monitoring and care market due to the increasing investment in RPM and care, which is expected to boost the market growth. The U.S. is expected to dominate the North America region due to the rise in technological advancement in RPM and care products. Germany is expected to dominate the Europe region due to the increasing demand from emerging markets and expansion. China is expected to dominate the Asia-Pacific region due to the increasing customer inclinations toward advanced technological processes.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Remote Patient Monitoring and Care Market Share Analysis
The global remote patient monitoring and care market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players operating in the global remote patient monitoring and care market are Medtronic, Boston Scientific Corporation, VitalConnect, Biobeat, General Electric, Koninklijke Philips N.V., OMRON Corporation, Abbott, Nihon Kohden Corporation, Vivify Health, Inc., Aerotel Medical Systems, BIOTRONIK SE & Co. KG, A&D Company, Limited, AliveCor, Inc., Masimo, Dexcom, Inc., Senseonics, Inc., ResMed, 100Plus., ChroniSense Medical, Ltd., Vitls, cardiomo, CoachCare, neteera, and Withings among others.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 VALUE CHAIN ANALYSIS:
4.3 COMPETITIVE ANALYSIS
4.4 BRAND ANALYSIS
4.5 ECOSYSTEM MAPS
4.6 TECHNOLOGICAL TRENDS
4.7 TOP WINNING STRATEGIES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING
5.1.4 INCREASING GOVERNMENT INITIATIVES
5.2 RESTRAINTS
5.2.1 STRICT REGULATORY FRAMEWORK
5.2.2 LACK OF STANDARDIZATION
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS
5.4.2 RISK TO PATIENT'S DATA SECURITY
6 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE
6.1 OVERVIEW
6.2 CARDIAC MONITORING DEVICES
6.3 BLOOD PRESSURE MONITORING DEVICES
6.4 MULTI-PARAMETER MONITORING DEVICES
6.5 BLOOD GLUCOSE MONITORING DEVICES
6.6 RESPIRATORY MONITORING DEVICES
6.7 NEUROLOGICAL MONITORING DEVICES
6.8 OTHERS
7 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CARDIOVASCULAR DISEASE
7.2.1 CORONARY HEART DISEASE
7.2.2 STROKE
7.2.3 PERIPHERAL ARTERIAL DISEASE
7.2.4 AORTIC DISEASE
7.2.5 OTHERS
7.3 DIABETES
7.4 ONCOLOGY
7.5 OTHERS
8 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER
8.1 OVERVIEW
8.2 HOME HEALTHCARE PATIENTS
8.2.1 BLOOD GLUCOSE MONITORING DEVICES
8.2.2 CARDIAC MONITORING DEVICES
8.2.3 BLOOD PRESSURE MONITORING DEVICES
8.2.4 MULTI-PARAMETER MONITORING DEVICES
8.2.5 RESPIRATORY MONITORING DEVICES
8.2.6 NEUROLOGICAL MONITORING DEVICES
8.2.7 OTHERS
8.3 AMBULATORY PATIENTS
8.3.1 MULTI-PARAMETER MONITORING DEVICES
8.3.2 RESPIRATORY MONITORING DEVICES
8.3.3 CARDIAC MONITORING DEVICES
8.3.4 BLOOD PRESSURE MONITORING DEVICES
8.3.5 BLOOD GLUCOSE MONITORING DEVICES
8.3.6 NEUROLOGICAL MONITORING DEVICES
8.3.7 OTHERS
8.4 HOSPITAL-BASED PATIENTS
8.4.1 MULTI-PARAMETER MONITORING DEVICES
8.4.2 CARDIAC MONITORING DEVICES
8.4.3 RESPIRATORY MONITORING DEVICES
8.4.4 BLOOD PRESSURE MONITORING DEVICES
8.4.5 BLOOD GLUCOSE MONITORING DEVICES
8.4.6 NEUROLOGICAL MONITORING DEVICES
8.4.7 OTHERS
9 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 U.K.
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 RUSSIA
9.3.6 SPAIN
9.3.7 TURKEY
9.3.8 SWITZERLAND
9.3.9 NETHERLANDS
9.3.10 BELGIUM
9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 AUSTRALIA
9.4.4 INDIA
9.4.5 SOUTH KOREA
9.4.6 SINGAPORE
9.4.7 MALAYSIA
9.4.8 THAILAND
9.4.9 INDONESIA
9.4.10 PHILIPPINES
9.4.11 REST OF ASIA-PACIFIC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 ARGENTINA
9.5.3 REST OF SOUTH AMERICA
9.6 MIDDLE EAST AND AFRICA
9.6.1 SOUTH AFRICA
9.6.2 EGYPT
9.6.3 ISRAEL
9.6.4 UAE
9.6.5 SAUDI ARABIA
9.6.6 REST OF MIDDLE EAST AND AFRICA
10 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 DEXCOM, INC.
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 RESMED
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 BIOTRONIK SE & CO. KG
12.5.1 COMPANY SNAPSHOT
12.5.2 COMPANY SHARE ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENT
12.6 100 PLUS.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 A&D COMPANY, LIMITED
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 COMPANY SHARE ANALYSIS
12.7.4 PRODUCT PORTFOLIO
12.7.5 RECENT DEVELOPMENT
12.8 AEROTEL MEDICAL SYSTEMS
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 ALIVECOR, INC.
12.9.1 COMPANY SNAPSHOT
12.9.2 COMPANY SHARE ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS
12.1 BIOBEAT
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
12.11 BOSTON SCIENTIFIC CORPORATION
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 COMPANY SHARE ANALYSIS
12.11.4 PRODUCT PORTFOLIO
12.11.5 RECENT DEVELOPMENT
12.12 CARDIOMO
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENTS
12.13 CHRONISENSE MEDICAL, LTD.
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENT
12.14 COACHCARE
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
12.14.3 RECENT DEVELOPMENT
12.15 GENERAL ELECTRIC
12.15.1 COMPANY SNAPSHOT
12.15.2 REVENUE ANALYSIS
12.15.3 COMPANY SHARE ANALYSIS
12.15.4 PRODUCT PORTFOLIO
12.15.5 RECENT DEVELOPMENT
12.16 KONINKLIJKE PHILIPS N.V.
12.16.1 COMPANY SNAPSHOT
12.16.2 REVENUE ANALYSIS
12.16.3 COMPANY SHARE ANALYSIS
12.16.4 PRODUCT PORTFOLIO
12.16.5 RECENT DEVELOPMENT
12.17 MASIMO
12.17.1 COMPANY SNAPSHOT
12.17.2 REVENUE ANALYSIS
12.17.3 COMPANY SHARE ANALYSIS
12.17.4 PRODUCT PORTFOLIO
12.17.5 RECENT DEVELOPMENT
12.18 NETEERA
12.18.1 COMPANY SNAPSHOT
12.18.2 PRODUCT PORTFOLIO
12.18.3 RECENT DEVELOPMENT
12.19 NIHON KOHDEN CORPORATION
12.19.1 COMPANY SNAPSHOT
12.19.2 REVENUE ANALYSIS
12.19.3 COMPANY SHARE ANALYSIS
12.19.4 PRODUCT PORTFOLIO
12.19.5 RECENT DEVELOPMENT
12.2 OMRON CORPORATION
12.20.1 COMPANY SNAPSHOT
12.20.2 REVENUE ANALYSIS
12.20.3 COMPANY SHARE ANALYSIS
12.20.4 PRODUCT PORTFOLIO
12.20.5 RECENT DEVELOPMENT
12.21 SENSEONICS, INC.
12.21.1 COMPANY SNAPSHOT
12.21.2 REVENUE ANALYSIS
12.21.3 COMPANY SHARE ANALYSIS
12.21.4 PRODUCT PORTFOLIO
12.21.5 RECENT DEVELOPMENT
12.22 VITALCONNECT
12.22.1 COMPANY SNAPSHOT
12.22.2 PRODUCT PORTFOLIO
12.22.3 RECENT DEVELOPMENT
12.23 VITLS
12.23.1 COMPANY SNAPSHOT
12.23.2 PRODUCT PORTFOLIO
12.23.3 RECENT DEVELOPMENT
12.24 VIVIFY HEALTH INC.
12.24.1 COMPANY SNAPSHOT
12.24.2 PRODUCT PORTFOLIO
12.24.3 RECENT DEVELOPMENTS
12.25 WITHINGS
12.25.1 COMPANY SNAPSHOT
12.25.2 COMPANY SHARE ANALYSIS
12.25.3 PRODUCT PORTFOLIO
12.25.4 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
Liste des tableaux
TABLE 1 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 2 GLOBAL CARDIAC MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL BLOOD PRESSURE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL MULTI-PARAMETER MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL BLOOD GLUCOSE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL RESPIRATORY MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL NEUROLOGICAL MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 GLOBAL CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 GLOBAL DIABETES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 GLOBAL ONCOLOGY IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 GLOBAL OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 16 GLOBAL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 GLOBAL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 18 GLOBAL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 GLOBAL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 20 GLOBAL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 GLOBAL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 22 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 31 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 32 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 33 U.S. CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 34 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 35 U.S. HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 36 U.S. AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 37 U.S. HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 38 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 39 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 40 CANADA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 41 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 42 CANADA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 43 CANADA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 44 CANADA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 45 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 46 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 47 MEXICO CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 48 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 49 MEXICO HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 50 MEXICO AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 51 MEXICO HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 52 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 53 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 54 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 EUROPE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 56 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 57 EUROPE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 58 EUROPE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 59 EUROPE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 60 GERMANY REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 61 GERMANY REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 62 GERMANY CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 63 GERMANY REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 64 GERMANY HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 65 GERMANY AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 66 GERMANY HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 67 U.K REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 68 U.K REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 U.K CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 U.K REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 71 U.K HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 72 U.K AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 73 U.K HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 74 FRANCE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 75 FRANCE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 FRANCE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 77 FRANCE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 78 FRANCE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 79 FRANCE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 80 FRANCE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 81 ITALY REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 82 ITALY REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 83 ITALY CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 84 ITALY REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 85 ITALY HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 86 ITALY AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 87 ITALY HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 88 RUSSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 89 RUSSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 90 RUSSIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 91 RUSSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 92 RUSSIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 93 RUSSIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 94 RUSSIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 95 SPAIN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 96 SPAIN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 97 SPAIN CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 98 SPAIN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 99 SPAIN HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 100 SPAIN AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 101 SPAIN HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 102 TURKEY REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 103 TURKEY REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 TURKEY CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 TURKEY REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 106 TURKEY HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 107 TURKEY AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 108 TURKEY HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 109 SWITZERLAND REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 110 SWITZERLAND REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 111 SWITZERLAND CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 112 SWITZERLAND REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 113 SWITZERLAND HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 114 SWITZERLAND AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 115 SWITZERLAND HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 116 NETHERLANDS REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 117 NETHERLANDS REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 118 NETHERLANDS CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 119 NETHERLANDS REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 120 NETHERLANDS HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 121 NETHERLANDS AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 122 NETHERLANDS HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 123 BELGIUM REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 124 BELGIUM REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 125 BELGIUM CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 126 BELGIUM REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 127 BELGIUM HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 128 BELGIUM AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 129 BELGIUM HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 130 REST OF EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 131 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 132 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 133 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 134 ASIA-PACIFIC CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 135 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 136 ASIA-PACIFIC HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 137 ASIA-PACIFIC AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 138 ASIA-PACIFIC HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 139 CHINA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 140 CHINA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 CHINA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 CHINA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 143 CHINA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 144 CHINA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 145 CHINA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 146 JAPAN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 147 JAPAN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 148 JAPAN CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 149 JAPAN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 150 JAPAN HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 151 JAPAN AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 152 JAPAN HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 153 AUSTRALIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 154 AUSTRALIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 155 AUSTRALIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 156 AUSTRALIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 157 AUSTRALIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 158 AUSTRALIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 159 AUSTRALIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 160 INDIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 161 INDIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 162 INDIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 163 INDIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 164 INDIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 165 INDIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 166 INDIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 167 SOUTH KOREA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 168 SOUTH KOREA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 SOUTH KOREA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 170 SOUTH KOREA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 171 SOUTH KOREA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 172 SOUTH KOREA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 173 SOUTH KOREA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 174 SINGAPORE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 175 SINGAPORE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 SINGAPORE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 SINGAPORE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 178 SINGAPORE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 179 SINGAPORE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 180 SINGAPORE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 181 MALAYSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 182 MALAYSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 183 MALAYSIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 184 MALAYSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 185 MALAYSIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 186 MALAYSIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 187 MALAYSIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 188 THAILAND REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 189 THAILAND REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 190 THAILAND CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 191 THAILAND REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 192 THAILAND HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 193 THAILAND AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 194 THAILAND HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 195 INDONESIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 196 INDONESIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 197 INDONESIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 198 INDONESIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 199 INDONESIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 200 INDONESIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 201 INDONESIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 202 PHILIPPINES REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 203 PHILIPPINES REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 204 PHILIPPINES CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 205 PHILIPPINES REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 206 PHILIPPINES HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 207 PHILIPPINES AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 208 PHILIPPINES HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 209 REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 210 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 211 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 212 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 213 SOUTH AMERICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 214 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 215 SOUTH AMERICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 216 SOUTH AMERICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 217 SOUTH AMERICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 218 BRAZIL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 219 BRAZIL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 220 BRAZIL CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 221 BRAZIL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 222 BRAZIL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 223 BRAZIL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 224 BRAZIL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 225 ARGENTINA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 226 ARGENTINA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 227 ARGENTINA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 ARGENTINA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 229 ARGENTINA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 230 ARGENTINA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 231 ARGENTINA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 232 REST OF SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 233 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 234 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 235 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 236 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 237 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 238 MIDDLE EAST AND AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 239 MIDDLE EAST AND AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 240 MIDDLE EAST AND AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 241 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 242 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 243 SOUTH AFRICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 245 SOUTH AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 246 SOUTH AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 247 SOUTH AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 248 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 249 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 EGYPT CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 251 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 252 EGYPT HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 253 EGYPT AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 254 EGYPT HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 255 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 256 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 257 ISRAEL CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 258 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 ISRAEL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 260 ISRAEL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 261 ISRAEL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 262 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 263 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 264 UAE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 265 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 266 UAE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 267 UAE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 268 UAE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 269 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 270 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 271 SAUDI ARABIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 272 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 273 SAUDI ARABIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 274 SAUDI ARABIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 275 SAUDI ARABIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 276 REST OF MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 2 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET IN THE FORECAST PERIOD
FIGURE 12 THE CARDIAC MONITORING DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET IN 2023 AND 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET AND EUROPE IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 EUROPE IS THE FASTEST-GROWING MARKET FOR THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET MANUFACTURERS IN THE FORECAST PERIOD
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET
FIGURE 16 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2022
FIGURE 17 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2023-2030 (USD MILLION)
FIGURE 18 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, CAGR (2023-2030)
FIGURE 19 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, LIFELINE CURVE
FIGURE 20 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2022
FIGURE 21 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 22 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 23 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 24 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2022
FIGURE 25 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 26 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 27 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, LIFELINE CURVE
FIGURE 28 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 29 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY REGION (2022)
FIGURE 30 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY REGION (2023 & 2030)
FIGURE 31 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY REGION (2022 & 2030)
FIGURE 32 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE (2023-2030)
FIGURE 33 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 34 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 35 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 36 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 37 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 38 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 40 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 43 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: SNAPSHOT (2022)
FIGURE 44 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: BY COUNTRY (2022)
FIGURE 45 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 46 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 47 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: DEVICE TYPE (2023-2030)
FIGURE 48 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 49 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 50 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 51 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 52 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 53 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 54 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 55 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 56 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 57 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 58 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
FIGURE 59 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
FIGURE 60 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
FIGURE 61 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
